First gene regulation clinical trials for epilepsy show promising results
Medical Xpress
March 4, 2026
A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and well tolerated by patients with Dravet syndrome for whom antiseizure medications are not effective.
Verticals
healthmedical
Originally published on Medical Xpress on 3/4/2026